Impact of a Weekly Glucagon-Like Peptide 1 Receptor Agonist, Albiglutide, on Glycemic Control and on Reducing Prandial Insulin Use in Type 2 Diabetes Inadequately Controlled on Multiple Insulin Therapy: A Randomized Trial
The IDNT ( Irbesartan Diabetic Nephropathy Trial ) with 300 mg of irbesartan, 10 mg of amlodipine, or placebo, shown that Irbesartan was superior to both placebo and amlodipine in reducing the risk of doubling of serum creatinine, end-stage kidney disease (ESKD), or all-cause mortality (42)
Monetary choice questionnaire
A Rybelsus generic is not approved in the United States or Canada at this time
Wang Z, Koirala B, Hernandez Y, Zimmerman M, Brady SF (2022c) Bioinformatic prospecting and synthesis of a bifunctional lipopeptide antibiotic that evades resistance